Crowley Wealth Management »

BioCryst Pharmaceuticals shares owned by Crowley Wealth Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Crowley Wealth Management from 13F filings

Historical chart of Crowley Wealth Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Crowley Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Crowley Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $19k 2.5k 7.59
2025-06-30 $22k 2.5k 8.96
2025-03-31 $19k 2.5k 7.50
2024-12-31 $19k 2.5k 7.52

More positions owned by Crowley Wealth Management

Apple Common Stock (AAPL)
Tesla Common Stock (TSLA)
Proshares Ultra Qqq Etf Uit Exchange Traded (QLD)
Abbvie Common Stock (ABBV)
Lowes Cos Common Stock (LOW)
Proshares Ultra S&p 500 Etf Uit Exchange Traded (SSO)
Microsoft Corp Common Stock (MSFT)
Jpmorgan Chase & Co Common Stock (JPM)
Home Depot Common Stock (HD)
Proshares Ultra Russell 2000 Etf Uit Exchange Traded (UWM)
Disney Walt Common Stock (DIS)
Amgen Common Stock (AMGN)
Stryker Corp Common Stock (SYK)
Amazon.com Common Stock (AMZN)
Abbott Labs Common Stock (ABT)

View all positions for Crowley Wealth Management

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
BlackRock
Deerfield Management Company
State Street Corporation
Kynam Capital Management
UBS Group
Alkeon Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Hood River Capital Management
Nuveen
Assenagon Asset Management

View all funds holding BioCryst Pharmaceuticals